The metabolism of immune cells affects their function and influences host immunity. This review explores how immune cell metabolic phenotypes reflect biochemical dependencies and highlights evidence that both the metabolic state of immune cells and nutrient availability can alter immune responses. The central importance of oxygen, energetics, and redox homeostasis in immune cell metabolism, and how these factors are reflected in different metabolic phenotypes, is also discussed. Linking immune cell metabolic phenotype to effector functions is important to understand how altering metabolism can impact the way in which immune cells meet their metabolic demands and affect the immune response in various disease contexts.
Introduction
All cells regulate their metabolism to support the biochemical demands of cell-type-specific functions. The biochemical requirements of immune cells vary among different effector subsets and change over the course of an immune response. Naive lymphocytes must rapidly engage a proliferative metabolic program when foreign antigens are encountered , macrophages must support an enzymatic program to process phagocytosed material (Park et al., 2011; Van den Bossche et al., 2017) , and neutrophils must undergo a rapid respiratory burst to effectively destroy pathogens (El-Benna et al., 2016) . In each case, cellular metabolism is adapted to allow each immune cell type to carry out its unique function and protect the host from pathogens and malignancy. Emerging data demonstrate that the metabolic state of immune cell populations is intimately tied to cellular differentiation and the activation of effector functions. Concurrently, immune cells encounter variations in nutrients, temperature, pH, and O 2 as they traffic throughout the body, and these microenvironmental factors also impact metabolism and immune cell functions. Understanding how the interactions among immune cell biochemical requirements, cellular metabolic state, and nutrient availability interact to shape the immune response is critical to move beyond ''metabolic phenotyping'' to a more complete understanding of immune cell metabolism.
Metabolic phenotypes are often studied in cell culture, where nutrients are in excess and immune cells are separated from other tissue-resident cells. In recent years, disease models and clinical studies have begun to dissect the influence that local or systemic environmental factors have on the metabolism of tumor cells and immune cells, and there is growing evidence that systemic metabolic factors and local nutrient limitations at immune effector sites can be obstacles to both antimicrobial and anti-tumor immunity (Flint et al., 2016) . Many cancer chemotherapies that target nucleotide metabolism also cause immunosuppression, increasing the risk of infection in cancer patients.
Furthermore, the notion that cancer therapies might act, in part, by altering the tumor microenvironment and affecting immune cell function has generated interest in targeting immune cell metabolism to treat cancer (Chang and Pearce, 2016) . It also raises the possibility that drugs targeting cancer metabolism might impair anti-tumor immunity, underscoring the importance of understanding the differences and similarities between immune and tumor cell metabolism and how this affects immune responses. This review will provide a framework for understanding immune cell metabolic phenotypes and attempt to connect metabolic phenotypes to the biochemical requirements of various immune cells.
Overview of Immune Cell Metabolic Phenotypes
Resting lymphocytes circulate in the blood, and cells in lymphoid tissues carry out surveillance for foreign antigens. Biosynthetic processes for these cells are minimal and they rely primarily on the mitochondrial oxidation of glucose and lipids to meet the energetic demands of survival and antigen surveillance. Homeostatic cues provided by molecules such as interleukin-7 that regulate T cell survival also are required for maintenance of this metabolic program (Jacobs et al., 2010) . T cell antigen receptor stimulation in the presence of inflammatory co-stimulation leads to activation of the phosphatidyl-inositide-3-kinase (PI3K)/Akt/ mTORC1 signaling pathway and induction of Myc, which promotes both aerobic glycolysis and increased glutamine metabolism and also drives increased lymphocyte numbers and size (Frauwirth et al., 2002; Wang et al., 2011; Jones and Pearce, 2017) . Glucose uptake increases and becomes limiting for T cell cytokine production and proliferation (Jacobs et al., 2008) . Mitochondrial oxidative metabolism also increases, although to an extent that is relatively less than the increase in aerobic glycolysis, leading to the notion that activated T cells rely predominantly on aerobic glycolysis (Figure 1 ; van der Windt et al., 2012; Wang et al., 2011) .
Aerobic glycolysis is a characteristic feature of many rapidly dividing cells, including cancer cells and immune cells, in which glucose is fermented to lactate, even when sufficient O 2 is present to support oxidative phosphorylation (OxPhos) (Roos and Loos, 1973; Vander Heiden et al., 2009; Wang et al., 1976) . It has been proposed that the advantage of this metabolic phenotype in proliferating cells is to help meet the biochemical requirements of biosynthesis and allow cell duplication (Lunt and Vander Heiden, 2011) . Indeed, aerobic glycolysis tracks with DNA synthesis in proliferating lymphocytes (Wang et al., 1976) . Additionally, aerobic glycolysis may also play important roles in T cell effector function. The glycolytic intermediate phosphoenolpyruvate has been suggested to promote calcium signaling essential for T cell activation (Ho et al., 2015) , and interferon-g has been shown to be reliant on high rates of glucose metabolism through both transcriptional and translational regulation (Cham and Gajewski, 2005; Chang et al., 2013; Peng et al., 2016) . Activation of lymphocytes is followed by differentiation into cell subsets with specific effector or suppressor functions and ultimately differentiation into long-lived memory cells. Where studied, each T cell subset has been found to display a unique metabolic program that supports the biochemical requirements of their distinct cellular functions (Beier et al., 2015; Gerriets et al., 2015; Michalek et al., 2011; Oestreich et al., 2014; Shi et al., 2011) . In general, effector T cell subsets predominantly display a glycolytic phenotype, while the anti-inflammatory regulatory T cell (Treg) subsets are characterized by the use of mitochondrial oxidative phosphorylation (Angelin et al., 2017) . Under certain conditions, Treg cells have been observed to exhibit aerobic glycolysis downstream of PI3K/Akt/mTORC1 signaling (Zeng et al., 2013) , but this metabolic phenotype is associated with reduced expression of the Treg cell transcription factor, FoxP3, and decreased suppressive function (Gerriets et al., 2016; Huynh et al., 2015; Park et al., 2013; Shrestha et al., 2015) . Memory T cells return to an oxidative phenotype when they become quiescent, and like naive T cells consume both glucose and lipids (Figure 1 ; Phan et al., 2016; van der Windt et al., 2012) . However, memory cells are metabolically distinct from naive T cells in that they are poised to rapidly engage a program involving increased aerobic glycolysis upon re-encounter with antigens (Gubser et al., 2013; van der Windt et al., 2013) .
Metabolic reprogramming in response to immune receptor stimulation is a common theme among many classes of immune cells in addition to lymphocytes. Stimulated macrophages and dendritic cells rapidly induce aerobic glycolysis after activation of pattern recognition receptors such as Toll-like receptors (TLRs) (O'Neill and Pearce, 2016) . Thus, aerobic glycolysis is not restricted to proliferating immune cells and instead better associates with cells undergoing anabolic processes. For example, TLR-stimulated dendritic cells increase glycolysis to support new lipid synthesis for rapid expansion of the endoplasmic reticulum and Golgi, processes necessary for production and secretion of immune regulatory cytokines . Like T cell subsets, myeloid cells have functionally distinct phenotypes associated with different metabolic programs. Classically activated macrophages that promote inflammation utilize glycolysis and glutamine metabolism to generate large quantities of succinate that enhances inflammation and production of interleukin-1 (Tannahill et al., 2013) . In contrast, macrophages that play a role in tissue healing and inflammatory resolution display more mitochondrial lipid oxidation (Vats et al., 2006) . A key differentiator between these metabolic phenotypes may arise in the mitochondria, where rather than engaging in conventional electron transport, altered electron flow through the succinate dehydrogenase complex promotes reactive oxygen species (ROS) generation and inflammation (Mills et al., 2016) . Inhibition of respiration in myeloid cells as a consequence of nitric oxide production for host defense may also be more tolerable because, unlike antigen-specific lymphocytes, myeloid cells can be regenerated by the bone marrow if mitochondrial inhibition results in cell death (Brown and Borutaite, 2002; Everts et al., 2012) . Macrophage metabolism has been recently reviewed in detail ( Van den Bossche et al., 2017) .
Ultimately, each immune cell metabolic phenotype is dependent on acquisition of appropriate nutrients. Indeed, forced expression of the glucose transporter Glut1 is associated with inflammatory T cells and is sufficient to promote a systemic lupus erythematosus-like phenotype in transgenic mice (Michalek et al., 2011 Immunity Review increase the inflammatory character of macrophages (Freemerman et al., 2014) . Conversely, Glut1 deficiency lowers glucose uptake and reduces T cell proliferation and inflammatory function in vivo. Treg cells, in contrast, are less dependent on glucose metabolism and appear to function normally in the absence of Glut1 . Access to amino acids is also critical, as cells deficient in specific amino acid transporters fail to activate mTORC1 and induce T cell-mediated inflammation (Nakaya et al., 2014; Sinclair et al., 2013) . Activation of mTORC1 can reprogram cell metabolism to support proliferation (D€ uvel et al., 2010) , and by extension, the availability of amino acids and other nutrients in the microenvironment will have a profound impact on immune cell metabolism and function. Understanding the interplay between metabolism, immune subset differentiation, and effector function requires a deeper understanding of how these various metabolic phenotypes support these functions and will shed light on how cells adapt to different physiological environments.
Oxygen, Oxidative Phosphorylation, and Aerobic Glycolysis Most immune cell metabolic phenotypes are considered with respect to cellular energetics, including the manner by which cells produce ATP to support otherwise unfavorable reactions (Box 1). Oxidative cells produce a larger fraction of cellular ATP from mitochondrial oxidative phosphorylation, while glycolytic cells produce relatively more ATP from glycolysis. Some immune cells transition between oxidative and glycolytic metabolic phenotypes over the course of an immune response, and manipulation of this dichotomy can impact immunity. In exploring the importance of these metabolic phenotypes, it is helpful to recall the central importance of O 2 in metabolism. Metazoan life is distinctly aerobic, and even brief interruptions in O 2 supply can have profound effects on cellular function and viability. ATP production by either oxidative phosphorylation or glycolysis requires nutrient oxidation, i.e., removal of electrons from nutrients such as glucose (Figures 1 and 2 ; Vander Heiden and DeBerardinis, 2017). Oxygen is the prototypic oxidizing agent, and its role as the terminal electron acceptor in the mitochondrial respiratory chain is generally appreciated. In addition, O 2 is directly or indirectly required for numerous biochemical reactions (Goldfine, 1965; Raymond and Segrè , 2006) . Oxygen is essential for the synthesis of sterols and unsaturated fatty acids as well as the diverse biosynthetic, signaling, and epigenetic functions carried out by the large family of aKG-dependent dioxygenases (Loenarz and Schofield, 2011) . Within the immune system, O 2 has a particularly important role in granulocyte ROS production for host defense (El-Benna et al., 2016; Mills et al., 2016; West et al., 2011) . The amount of O 2 consumed by non-mitochondrial reactions can be physiologically significant (Banh et al., 2016) .
Despite its central importance to metabolic phenotypes, O 2 concentration is often an experimental unknown, and when it has been measured in vivo, technical considerations can influence measurement accuracy (Wilson, 2008) . Oxygen concentration is linearly related to the partial pressure of O 2 (pO 2 ). In experiments performed in standard tissue culture conditions, media pO 2 is near 145 mm Hg, or an O 2 concentration of $200 mM. However, it has been estimated that the pO 2 adjacent to an adherent cell monolayer can vary significantly, with reported values ranging from 0 mm Hg to greater than 100 mm Hg (Bambrick et al., 2011; Metzen et al., 1995; Wolff et al., 1993) . The concentration of any metabolic substrate, including O 2 , is a balance between its rate of appearance and 
Term Common Definition Considerations
Oxidative Cell A cell that converts most of the consumed glucose to CO 2 in the mitochondrial TCA cycle.
The distinguishing feature of a glycolytic cell is lactate production. Glycolytic cells still rely on oxidative TCA cycle flux and mitochondrial respiration. In fact, O 2 consumption can be higher in glycolytic cells as compared to ''oxidative'' quiescent cells, as total nutrient uptake is increased. Fuel oxidation is required for survival of all cells, and both pyruvate reduction to lactate and O 2 reduction to water enable fuel oxidation.
Glycolytic Cell A cell that converts most of the consumed glucose to lactate.
Aerobic Glycolysis High rate of lactate production from glucose despite normoxia.
A high rate of lactate production does not mean that mitochondrial respiration is necessarily suppressed. SRC implies that O 2 consumption is less than maximum, possibly because a high energy state limits use of the proton gradient to drive ATP synthesis. The total respiratory capacity of a cell is a measure of the capacity of cells to make ATP via oxidative phosphorylation, but also the capacity for fuel oxidation and NADH recycling. Cells with SRC can increase nutrient oxidation if demands for either ATP or biomass increase, provided nutrients remain available. disappearance. As pertains to O 2 , this is a balance between O 2 delivery and the oxygen consumption rate (OCR). In tissue culture, O 2 delivery is determined by atmospheric conditions, media depth and aeration, and O 2 diffusion. Oxygen consumption rate is determined by several factors discussed below, including cell number and metabolic state. Therefore, cells cultured in ''normoxia'' (i.e., unregulated atmospheric pO 2 ) can in fact experience relative hypoxia if cells with high OCR are grown at high density. Conversely, cells with low OCR at low density can be exposed to supraphysiologic O 2 concentrations in culture. In tissues, pO 2 is tightly controlled within a narrow range, as O 2 delivery via the vasculature is highly regulated (Duncker and Bache, 2008; Poole et al., 2013) . Large contributors to O 2 delivery include arterial oxygen content (CaO 2 ), capillary density and blood flow, distance from the nearest blood vessel, and-importantly-tissue pO 2 and as well as metabolic regulators of microvascular function and oxyhemoglobin unloading.
Oxygen delivery has perhaps been most studied in cardiac physiology. The heart extracts $70% of the coronary CaO 2 under basal conditions to support the high ATP needs of beating cardiomyocytes (Deussen et al., 2012) . The coronary sinus, which drains the heart, is thought to be the most deoxygenated blood of the body with a pO 2 near 20 mm Hg (Mik et al., 2009 ). This illustrates that the most aerobic organ of the body (gram À1 ) maintains a low tissue pO 2 but relies heavily on oxidative metabolism to maximize ATP production and carry out its physiological function for the organism. Thus, pO 2 may not always be a good predictor of metabolic phenotype. This conclusion is supported by the fact that hypoxic stem cell microenvironments within the bone marrow are largely dependent on cellularity, i.e., low pO 2 in the bone marrow is in part determined by the high O 2 consumption of cells in those niches (Spencer et al., 2014) . It has also been observed that O 2 consumption by nonmitochondrial dioxygenases can impact pO 2 in poorly vascularized tumors (Banh et al., 2016) . A common misconception is that the interdependence between pO 2 on OCR is entirely reciprocal and that pO 2 directly determines the rate of cellular respiration and oxidative phosphorylation. In this view, aerobic glycolysis in proliferating cells is a paradox. The rate of oxidative phosphorylation is controlled by multiple variables in addition to pO 2 , including availability of oxidizable substrates, mitochondrial content, mitochondrial NAD + /NADH ratio, pH, and cellular energy state ð½ATP=ð½ADP3½P i ÞÞ (Wilson, 2015; Wilson et al., 1974) . ATP production is regulated to match ATP consumption, and all aspects of mitochondrial metabolism-TCA flux, NAD(H) metabolism, and respiration-are tightly coupled in most cells (Figure 2) .
It has been argued that when pO 2 becomes rate-limiting for mitochondrial respiration, the immediate decrease in cellular energy state and increased [ADP] can maintain mitochondrial respiratory rate (Wilson, 2015) . Thus, reliance on pO 2 alone to adapt metabolism to microenvironmental conditions has energetic and redox consequences, and cells have evolved additional means to adapt metabolism to hypoxia.
Cells sense pO 2 via the EGLN (also called PHD) family of enzymes (Kaelin et al., 2016) . These enzymes are a-ketoglutarate-dependent dioxygenases, with a Km for O 2 > 200 mM, well above tissue concentrations, making their enzymatic activity very responsive to changes in pO 2 (Hirsil€ a et al., 2003) . EGLNs hydroxylate the a-subunit of the hypoxia-inducible factor (HIFa), targeting this protein for degradation. HIF transcriptional activity is suppressed under conditions of high EGLN activity when O 2 is present at sufficient concentration (Kaelin and Ratcliffe, 2008) . A subset of HIF transcriptional targets increases glucose uptake and glycolysis and actively inhibits pyruvate oxidation (Kim et al., 2006; Papandreou et al., 2006) . These metabolic adaptations are predicted to (1) increase the contribution of substrate-level phosphorylation from glycolysis to ATP production and (2) limit the reduction in mitochondrial NAD + / NADH ratio under hypoxia. These adaptations are important to decrease mitochondrial respiration and match O 2 consumption to O 2 delivery, as they mitigate changes in energy state or mitochondrial NAD + /NADH ratio that might preserve respiratory rate at lower pO 2 . Additionally, decreased pyruvate oxidation under hypoxia might limit mitochondrial hyperpolarization and ROS production. In the longer term, hypoxia and HIF stabilization impairs mitochondrial biogenesis Figure 2 . Relationship between Glycolysis, Oxygen Consumption, ATP Production, and Redox Metabolism Glycolysis and mitochondrial respiration both supply cellular ATP. Production of lactate from pyruvate allows NAD + regeneration and maintenance of redox balance for glycolysis. Redox balance is maintained when pyruvate or fatty acids from lipids are oxidized in the mitochondrial TCA cycle by transfer of electrons to O 2 via the electron transport chain. When O 2 consumption is coupled to ATP production, the proton (H + ) gradient across the inner mitochondrial membrane generated by the electron transport chain is used to drive ATP synthesis (oxidative phosphorylation). Oxygen consumption can also be uncoupled from ATP production if there is another route for protons to cross the inner mitochondrial membrane (uncoupled respiration). This can occur via endogenous uncoupling proteins or via pharmacologic agents such as FCCP that are used to assess spare respiratory capacity. Production of lactate or consumption of O 2 at rates that are stoichiometric with nutrient oxidation is necessary for electron disposal and redox homeostasis in cell metabolism.
perspective of a proliferating cell, the HIF metabolic program favors pyruvate reduction over oxidation, preserving NAD + /NADH ratio to facilitate oxidative biosynthesis when a major electron acceptor, O 2 , is in limited supply.
The importance of mitochondrial respiration in cellular energetics is more widely appreciated than the role of the respiratory chain in cellular redox homeostasis. Oxygen reduction to water is one of the primary outputs of the mitochondrial respiratory chain, and in certain contexts this function is more important than its role in ATP synthesis (Birsoy et al., 2015; Sullivan et al., 2015) . For example, the ATP synthase inhibitor oligomycin blocks mitochondrial respiration and is toxic to cells; however, addition of an uncoupling agent that restores mitochondrial respiration (but not ATP production) can rescue both survival and proliferation in oligomycin-treated cells (Sullivan et al., 2015) . Similarly, cells with genetic defects in mitochondrial respiration can survive and proliferate, but only if they are provided sufficient quantities of an alternative, practicable electron acceptor such as pyruvate (King and Attardi, 1989) . Pyruvate reduction to lactate and O 2 reduction to water both produce reduced products, causing regeneration of the oxidized cofactor NAD + from its reduced form NADH and facilitate electron disposal ( Figure 2 ). While glycolysis can produce sufficient ATP to support cell proliferation, glycolysis is net redox neutral. Therefore, glycolysis alone cannot support the production of oxidized molecules needed for cell division, such as nucleotides (Figure 1 ). Mitochondrial respiration is therefore critical in all cells, even those exhibiting high rates of aerobic glycolysis (Joshi et al., 2015; Martínez-Reyes et al., 2016; Weinberg et al., 2010; Zu and Guppy, 2004) . Interestingly, many cells with intact mitochondrial respiration proliferate faster in tissue culture when supplemented with excess pyruvate, which increases NAD + regeneration from NADH. The tight correlation between cellular NAD + /NADH ratio, respiratory rate, and proliferation rate highlights the importance of electron acceptors in creation of new biomass during cell division (Gui et al., 2016; Titov et al., 2016) . The low NAD + /NADH ratio associated with oxidative biosynthesis is one explanation for why many proliferating cell types use aerobic glycolysis (Vander Heiden and DeBerardinis, 2017) .
Glucose is the most highly consumed fuel of proliferating cells, including cancer cells and proliferating lymphocytes. Glucose is needed to produce ribose used in nucleotide biosynthesis, glycolytic intermediates that contribute to amino acid metabolism, and NADPH via the oxidative pentose phosphate pathway (Lunt and Vander Heiden, 2011; Sagone et al., 1974) . NADPH provides the cellular reducing potential for biosynthetic reactions such as cholesterol and lipid biosynthesis (Fan et al., 2014; Lewis et al., 2014) and is needed to maintain reduced glutathione, which has diverse functions in cellular redox homeostasis. However, in proliferating cells glucose contributes only $10% to cellular biomass, with most glucose converted to lactate in near equimolar amounts Hume et al., 1978; Sagone et al., 1974) . The fact that glucose is not a major carbon source for cell mass does not mean glycolysis is not important for proliferating cells. It has been argued that glycolytic ATP production provides metabolic flexibility to maintain energy state when OxPhos is limited by low pO 2 in microenvironments such as the bone marrow or in a hypoxic tumor. It has also been argued that glycolysis permits faster ATP production than OxPhos (Koppenol et al., 2011) or that the decreased biosynthetic cost of producing glycolytic enzymes relative to OxPhos machinery is an advantageous energetic solution for proliferating cells (Shlomi et al., 2011) . One certainty is that increased ATP production by glycolysis can decrease mitochondrial respiratory rate by increasing the cellular energy state. It should be noted that aerobic glycolysis is a common occurrence in normal physiology (Bulusu et al., 2017; Lindsay et al., 2014; Magistretti, 2016; O'Connor, 1952) , and it is estimated that the basal rate of lactate production in humans is approximately 1 mmol/kg/hr (Connor and Woods, 1982) . Lactate is produced in conditions where pyruvate production exceeds the rate of pyruvate oxidation and cytosolic NAD + /NADH is reduced. Pyruvate production can be increased by conditions that increase ATP consumption, such as exercise (James et al., 1999) or in response to high levels of catechols in sepsis (Garcia-Alvarez et al., 2016; Levy et al., 2005) . In proliferating cells, growth factor-mediated increases in glucose uptake, high ATP consumption associated with cell growth, and low NAD + /NADH ratio secondary to oxidative biosynthesis can all contribute to increase lactate production and this may underlie the broad use of aerobic glycolysis in proliferating cells (Vander Heiden and DeBerardinis, 2017).
Spare Respiratory Capacity
Differences in spare respiratory capacity (SRC) represent a prominent difference in metabolic phenotype among some immune cell subsets. Spare respiratory capacity is defined as the increase in OCR elicited by exposure to agents such as FCCP that uncouple mitochondrial O 2 consumption from ATP production (Figure 2 ; Huang et al., 2014; van der Windt et al., 2012 van der Windt et al., , 2001 . The existence of SRC requires that the cellular energy state ð½ATP=ð½ADP3½P i ÞÞ is sufficiently high that the demand for ATP synthesis is limiting the rate of electron transport (Figure 2 ). Thus, in cells with high SRC, OCR is limited by energy excess and not by substrate. The biological importance of SRC remains a source of debate. This phenotype may reflect a metabolic adaptation in some cells to increase their capacity for oxidative metabolism to produce ATP or for another process in which mitochondrial electron transport is required, and it may or may not be coupled to ATP synthesis (Sena et al., 2013) .
Potential Biochemical Basis for Select Immune Cell Metabolic Phenotypes
We propose a model that incorporates principles of metabolic regulation to explain T cell phenotypes (Figure 3 ). Naive T cells have few mitochondria as well as low ATP requirements to maintain homeostasis. Pyruvate production in a naive T cell approximates the rate of pyruvate oxidation in the mitochondrial TCA cycle, and little lactate is produced. After stimulation by foreign peptide-MHC and CD28 co-stimulation, T cells engage a proliferative program and their capacity for glucose uptake and pyruvate generation increases substantially, coincident with upregulation of genes encoding enzymes for glycolysis and the respiratory chain (Best et al., 2013; Jacobs et al., 2008) . Demand for nucleotides and other oxidized biomass increases to support rapid cell proliferation, while the main process for disposing of electrons-cellular respiration-can be limited by low mitochondrial number and oxidation capacity, O 2 availability, and/or a high energy state. This results in a lower cellular NAD + /NADH ratio, promoting pyruvate reduction to lactate. Thus, aerobic glycolysis reflects pyruvate production in excess of the cellular capacity for pyruvate oxidation, coupled with a low NAD + /NADH ratio. That is, lactate production in activated T cells is the result of the change in energetic, biosynthetic, and redox requirements of proliferation (Figures 1 and 2) . This model incorporates the importance of cellular respiration in proliferation and attributes high rates of lactate production to energetic excess, rather than energy deficiency. The model is consistent with observations that oligomycin-treated T cells can proliferate when excess glucose and pyruvate are available .
In a resolving immune response, T cell numbers contract and memory T cells are generated. Memory T cells are quiescent, non-dividing cells with a metabolic phenotype that is similar in many ways to naive cells (Figures 1 and 3) . However, these cells can proliferate and respond faster than naive T cells after antigen exposure. They have increased capacity for protein synthesis to support proliferation and effector functions, and increased mitochondria with increased spare respiratory capacity. Thus, their capacity for ATP consumption, ATP generation, and nutrient oxidation are high despite low nutrient uptake, perhaps facilitating an ability to rapidly engage a proliferative program with increased energetic and biosynthetic requirements. While the signaling events responsible for return to quiescence are poorly understood, it is clear that quiescence in central memory cells is maintained in part by low levels of glucose transporters; hence, the predominance of fatty acid oxidation in this T cell subset (Pan et al., 2017; van der Windt et al., 2012 van der Windt et al., , 2013 . In mammalian cells, fatty acids are unable to serve as an anaplerotic substrate for the TCA cycle to produce nucleotides and other biomass components, and the preference for this fuel may help limit proliferation until appropriate signals are provided to increase uptake of glucose and amino acids. Interestingly, forced maintenance of aerobic glycolysis during an immune response does not elimi- Naive T cells exhibit low glucose transporter expression and nutrient uptake, with metabolism directed toward nutrient oxidation and cell survival. Nutrient uptake and mitochondrial mass are increased upon T cell activation, facilitating the production of new biomass for proliferation. Memory T cells return to a low nutrient uptake state, again relying on nutrient oxidation to support cell survival; however, these cells retain more mitochondria (oxidation capacity) facilitating their ability to re-engage a proliferative program when reactivated. Exhausted T cells become limited for nutrient uptake and/or oxidizing capacity secondary to dysfunctional mitochondria limiting their ability to support a proliferative metabolic program.
nate memory T cells, but instead creates an effector memory cell phenotype, highlighting the importance of fuel limitation in promoting memory cell quiescence . Regardless, baseline respiratory rate is higher in memory T cells than in naive cells, reflecting reliance on fatty acid oxidation and OxPhos rather than glycolysis to make ATP. As occurs in naive T cell activation, response of memory cells to full antigen receptor stimulation activates a proliferative metabolic program with increased glucose uptake, increased nucleotide production (with a fall in NAD + /NADH ratio), and higher lactate production. Thus, the increased oxidative capacity afforded by the high mitochondrial mass in memory T cells as compared to a proliferating naive T cell may facilitate production of nucleotides and oxidized biomass that can be limiting for cell proliferation (Vander Heiden and DeBerardinis, 2017) and enable rapid clonal expansion when memory cells encounter antigen.
The capacity of a cell to oxidize fuels is intimately linked to its ability to perform effector functions and proliferate. As discussed above, quiescence in T cell subsets is associated with low levels of glucose transporters, while productive antigen-receptor stimulation is linked to transporter upregulation and increased glucose uptake. In this way, access to oxidizable nutrients is coordinated with metabolic demands to support proliferation. Similarly, imposed suppression of T cell oxidative capacity are coincident with active T cell suppression. In chronic immune responses such as occur in chronic infections or cancer, a phenomenon known as T cell exhaustion (Tex) occurs, associated with expression of the inhibitory co-receptor PD-1 and blunted effector functions (Bengsch et al., 2016; Wherry and Kurachi, 2015) . In Tex cells, cellular capacity for nutrient oxidation is limited by both low levels of glucose transporters and altered mitochondria (Figure 3) . Blockade of PD-1-PDL1 binding can reverse this metabolic program and restore anti-tumor immunity (Bengsch et al., 2016) . A similar phenomenon has been observed in tumor-infiltrating and tumor-associated lymphocytes (TILs) (Scharping et al., 2016) . T cells isolated from patients and from preclinical models of B cell leukemia are also exhausted and have low rates of glucose uptake and glycolysis. Restoration of glucose uptake can partially restore T cell activity, demonstrating that cancer-induced T cell metabolic impairments Immunity contribute to poor T cell function . Mitochondrial dysfunction also appears to play a key role in reduced TIL function as improved mitochondrial biogenesis and quality control could enhance anti-tumor immunity (Chamoto et al., 2017; Scharping et al., 2016) and T cells with low mitochondrial potential had greater ability to eliminate tumors in adoptive cell therapy (Sukumar et al., 2016) . Indeed, regulation of mitochondrial quality control may contribute to T cell longevity and generation of immunological memory (Adams et al., 2016) .
In the interpretation of T cell metabolic phenotypes provided, aerobic glycolysis as a characteristic of immune cell activation supports both ATP production and oxidative biosynthesis in these cells. A high rate of glycolytic ATP production may also provide immune cells the flexibility to use O 2 for purposes other than energetics. Macrophages display a variety of metabolic phenotypes (Van den Bossche et al., 2017) . Oxygen can be a limited resource in immune cell microenvironments and mitochondrial respiration is likely the largest O 2 consumer by many immune cells. Nevertheless, decreased reliance on OxPhos could enable increased activity of non-mitochondrial oxidases involved in biosynthesis or epigenetic regulation, both critically important for the function of numerous immune cell subsets (Phan et al., 2017) . Similarly, production of ROS by some immune cells is critical for host defense and may also be facilitated by a more glycolytic phenotype. Production of ATP by glycolysis and inhibiting ATP synthase to facilitate mitochondrial hyperpolarization will preserve O 2 availability as well as promote non-mitochondrial oxidase activity such as NOX (Mills et al., 2016) . Lactate production will also be increased in conjunction with a more reduced cell state that favors ROS generation. Using glycolysis to maintain energy state has the added benefit of providing a pyruvate ''buffer'' to maximize biochemical flexibility. Provided glycolysis maintains energy state, uncoupling of mitochondrial respiration from ATP production can facilitate oxidation of phagocytosed material (Park et al., 2011) . In summary, immune cell activation generates a change in energetic and redox state. Maintenance of energy state by glycolysis and generation of a pyruvate ''buffer'' provides maximal biochemical flexibility for cells to adapt to this change in state.
This model attempts to explain immune cell metabolic phenotypes in relation to biochemical requirements of cell functions and extends beyond ATP production as the only output of metabolism. All immune cell functions require ATP, whether it be production of new biomass and cytokines in a proliferating lymphocyte, antibody production in B cells, pathogen destruction, or oxidation of ingested biomass in phagocytes. The pathways used to generate the ATP may be a secondary consequence, and oxidative to glycolytic metabolic reprogramming might reflect biochemical requirements other than energetics. Many details of this model are untested; however, the model is consistent with data in other cell systems and generally consistent with principles of cellular energetics. The model highlights a few important points. First, the terminology used to describe metabolic phenotypes can be confusing (Box 1). Cells are described as ''oxidative'' when pyruvate production approximates pyruvate oxidation and ''glycolytic'' when lactate is produced. However, the rate of pyruvate oxidation and mitochondrial respiratory rate of a glycolytic proliferating T cell often exceeds the rate observed in a naive T cell given the higher total rate of nutrient uptake (Guppy et al., 1993; Hume et al., 1978) . Describing metabolic programs as either oxidative or glycolytic simplifies a complex relationship between cellular respiratory capacity, cellular redox requirements, cellular energetics, and fuel availability. Similarly, the presence or absence of spare respiratory capacity as a common phenotype in several immune cell subsets has been a source of confusion to many readers. Spare respiratory capacity is the magnitude of respiration increase after treatment of cells with FCCP or another drug that uncouples respiration from ATP production. Spare respiratory capacity, therefore, reflects a similarly complex relationship between total respiratory capacity and cellular energetics. Elucidating the underlying biochemical basis of many immune cell metabolic phenotypes can be challenging; however, as therapies targeting immunometabolism continue to show efficacy in altering immunity, improving this understanding might aid in the design of more effective therapeutics.
Influence of Available Nutrients on Immune Cell Metabolism
Accumulating data suggest that the microenvironment can have a profound effect on immune cell function (Chang and Pearce, 2016) . Dissecting how tissue environment affects immunometabolism can be challenging, because the conditions of nutrient excess used to culture cells in vitro are quite different from the microenvironment experienced by cells in tissues (Mayers and Vander Heiden, 2015) . A prominent example is the nutrient limitations immune cells experience within the tumor microenvironment, where poor vascular supply and high nutrient consumption by cancer cells combine to deplete available nutrients. It has been estimated that glucose is $10-fold lower in the tumor interstitium than it is in the plasma. T cells can adapt to low glucose by increasing glutamine metabolism (Blagih et al., 2015) , but low glucose levels within a tumor alters tumor-infiltrating lymphocyte (TIL) metabolism and effector function and represents a metabolic mechanism by which cancer cells can escape immune surveillance (Chang et al., , 2015 Ho et al., 2015) . In a glucose-poor environment, the decreased amount of glucose available to TILs leads to lower levels of glycolytic intermediates including phosphoenolpyruvate (PEP), which alters T cell receptor (TCR)-mediated calcium flux and T cell activation. Interestingly, this microenvironmental limitation can be overcome by genetic manipulation of enzyme expression to artificially raise PEP levels, providing proof-of-principle that modulating immune cell metabolism can directly influence immune responses (Ho et al., 2015) . Therapies that result in lower tumor cell glucose consumption might work in part by altering environmental conditions within the tumor to better support TIL function (Chang et al., 2015) . Similarly, the accumulation of metabolic products in the tumor microenvironment has important implications, such as the influence of high lactate concentration in tumors on macrophage polarization (Carmona-Fontaine et al., 2017; Colegio et al., 2014) . Finally, immune cell function can also be limited by amino acid availability. The observation that guinea pig serum could inhibit the growth of a murine lymphoma led to the purification of asparaginase as an antineoplastic enzymatic activity that was later found to also inhibit the growth of normal lymphocytes (Berenbaum, 1970; Broome, 1963; Kidd, 1953a Kidd, , 1953b . Environmental limitations of asparagine, tryptophan, serine (Ma et al., 2017) , and arginine have all been demonstrated to impact immune cell function under various conditions in vivo. The extensive literature studying amino acid deficiency on immune cell function has been recently reviewed elsewhere (Murray, 2016) .
Oxygen can be another limited resource for immune cells in vivo. While circulating immune cells are exposed to the O 2 concentration of blood ($75-100 mm Hg or $100-140 mM), the pO 2 of tissues is much lower, on average approaching the mixed venous pO 2 of 35-50 mm Hg. In the bone marrow, pO 2 measurements vary among microenvironmental niches, with a range between 10 and 22 mm Hg (Spencer et al., 2014) . A similar range of pO 2 has been reported in the spleen, whereas the pO 2 in the thymus is lower, closer to 10 mm Hg (Braun et al., 2001) . Cho et al. (2016) recently demonstrated that germinal centers have regional variations in pO 2 , with important consequences for B cell biology. In a tumor, pO 2 varies based on radial and longitudinal distance from the arterial supply, with areas that are well oxygenated and other areas that are anoxic (Koch and Evans, 2015) . While pO 2 is in part dependent on OCR of cells in those niches, hypoxia responses are observed in immune cells in vivo, providing physiologic evidence of O 2 limitation (Cho et al., 2016) . Hypoxia and inflammation are intimately connected (Eltzschig and Carmeliet, 2011) . Tissue hypoxia leads to inflammation, and high O 2 consumption by inflammatory cells can lead to hypoxia. HIF transcriptional activity been demonstrated to play an important role in macrophage subsets (Colegio et al., 2014; Cramer et al., 2003) , in B cell class-switching (Cho et al., 2016) , in CD8 + T cell differentiation Tyrakis et al., 2016) , and in determining the balance of Th17 and Treg cell differentiation Shi et al., 2011) . HIF has many transcriptional targets that are not directly involved in metabolism including epigenetic modifiers and transcription factors such as NF-kB and RORgt, which have established roles in immunity (Schö del et al., 2011) . Whether the metabolic effects of HIF are critical to support the biochemical needs of cell differentiation or immune effector functions remains an open question. Given the importance of mitochondrial respiration for cell proliferation and the importance of non-mitochondrial respiration in innate immunity, it is tempting to speculate that O 2 might be a limiting nutrient at sites of immune cell activation and influence the character and magnitude of immune responses.
Conclusions
The biochemical requirements of cell biology and physiology have been an active area of research for more than a century. Technologic advances have increased our ability to describe metabolic phenotypes, but we still rely on the lens of core biochemical principles to understand the complexity underlying differences in cell metabolism. This review has considered immune cell metabolic phenotypes within the context of the energetic and redox requirements of immune cell function. Many of the models and assumptions proposed are untested, and observations based on in vitro studies will require validation in vivo. Changes in metabolite levels can also directly affect cell state , and as new observations are made about the interdependence of immune cell metabolism and function, contextualizing those findings within core principles of biochemistry and physiology will be important to understand their role in host defense and exploit these relationships for patient benefit. 
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